(Q37849704)

24 August 2017

title

Trachoma and antibiotic use: the 'A' in SAFE. (English)

1 reference

24 August 2017

0 references

1

Sheila West

1 reference

24 August 2017

publication date

1 January 2012

1 reference

Expert Review of Anti-infective Therapy

24 August 2017

published in

1 reference

24 August 2017

volume

10

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

75-83

1 reference

Trachoma: global magnitude of a preventable cause of blindness

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Latrine ownership as a protective factor in inflammatory trachoma in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

The epidemiology of trachoma in central Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Village and household clustering of xerophthalmia and trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Estimating household and community transmission of ocular Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Analysis of the household distribution of trachoma in a Gambian village using a Monte Carlo simulation procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Incidence of trichiasis in a cohort of women with and without scarring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Chronic progressive conjunctival cicatrisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Long term outcome of trichiasis surgery in the Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Slow resolution of clinically active trachoma following successful mass antibiotic treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Evaluation of three years of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness and Environmental improvement) for trachoma control in five districts of Ethiopia hyperendemic for trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Mass treatment of trachoma with azithromycin 1.5% eye drops in the Republic of Cameroon: feasibility, tolerance and effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Azithromycin in control of trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Mass treatment with single-dose azithromycin for trachoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Global elimination of trachoma: how frequently should we administer mass chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Adverse events after mass azithromycin treatments for trachoma in Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Topical ocular antibiotics induce bacterial resistance at extraocular sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Decreased Susceptibility to Azithromycin and Doxycycline in Clinical Isolates of<i> Chlamydia trachomatis</i> Obtained from Recurrently Infected Female Patients in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Mass treatment with azithromycin for trachoma control: participation clusters in households

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Reduction and return of infectious trachoma in severely affected communities in Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Do infants increase the risk of re-emergent infection in households after mass drug administration for trachoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Randomized trial of high dose azithromycin compared to standard dosing for children with severe trachoma in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

The SAFE strategy for trachoma control: planning a cost-effectiveness analysis of the antibiotic component and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Azithromycin treatment coverage in Tanzanian children using community volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Simplification and improvement of height-based azithromycin treatment for paediatric trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Control of neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: proving the feasibility at national scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

Integrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.150

21 January 2018

Identifiers

DOI

10.1586/ERI.11.150

1 reference

24 August 2017

1 reference